Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Vasodilator lessens walking pain

  • Comment
Patients with intermittent claudication are less likely to experience pain in their legs when walking if they take the vasodilatory drug naftidrofuryl, according to the findings of a Cochrane Review.

Researchers studied seven clinical trials that compared naftidrofuryl with a placebo. They found patients who took 200mg of the drug – three times a day for at least three months – had 37% more pain-free walking than controls.

‘It would make sense to give naftidrofuryl alongside recommending lifestyle changes such as stopping smoking, physical exercise, and also prescribing anti-platelet drugs and statins,’ the reviewers said.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.